Vivo Bio Tech (BOM:511509) said it has received a Certificate of Good Laboratory Practice (GLP) compliance from the National GLP Compliance Monitoring Authority under India's Department of Science & Technology, according to an exchange filing on Monday.
The certification covers non-clinical safety and regulatory studies, including toxicity studies in dogs, carcinogenicity studies, and eye irritation or serious eye damage studies, including in vitro models aligned with international regulatory guidelines.
Shares of the company rose nearly 2% in recent trade.